Patent details

Basic Information

Publication number:

EP3049088

PCT Application Number:

IB2014002746

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148240914

PCT Publication Number:

WO2015044788

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING

French Title of Invention:

PROSTAGLANDINE F2ALPHA ET DES ANALOGUES DE CELLE-CI POUR LE TRAITEMENT DE LA CICATRISATION CUTANÉE ATROPHIQUE

German Title of Invention:

PROSTAGLANDIN F2ALPHA UND ANALOGE DAVON ZUR BEHANDLUNG VON ATROPHISCHER NARBENBILDUNG DER HAUT

SPC Number:

Dates

Filing date:

26/09/2014

Grant date:

17/02/2021

EP Publication Date:

03/08/2016

PCT Publication Date:

02/04/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/02/2021

EP B1 Publication Date:

17/02/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/09/2021

Expiration date:

26/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/02/2021

 

 

Name:

Galderma S.A.

Address:

World Trade Center Avenue Gratta-Paille 1,, 1000 Lausanne 30 Grey, Switzerland (CH)

Inventor

Name:

SCHERER, Warren J.

Address:

United States (US)

Priority

Priority Number:

201361960740 P

Priority Date:

26/09/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/5575; A61K 45/06; A61P 17/02; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202107

Publication date:

17/02/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages